Skip to main content
IBRX $6.02 -8.37%
IBRX logo
IBRX · ImmunityBio, Inc.
Track IBRX — free
$6.02 -0.55 (-8.37%) At close · Nov 20 Q4 2025 earnings call transcript
Market Cap
$6.40B
Shares
1.06B
Volume · Nov 20 10.64M Avg daily vol (3M) 12.89M
All webcasts

Earnings call · FY2025 Q1

ImmunityBio, Inc. (IBRX) Q1 2025 Earnings Call

Concluded Apr 15, 2025
Apr 15, 2025
Period
FY2025 Q1
Runtime
—
Sources
2 artifacts
Revenue $16.52M +41192.5% YoY
Diluted EPS -$0.15
Gross margin · derived Q4 99.6% -0.4 pp YoY
Net income -$129.65M
Open full screen 8-K 10-Q

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Quarter detail

How the reported period landed and where the business moved.

Revenue · products & services

Product$16.51M
Product And Service Other$8,000 -80% YoY
Full-screen source Call document